首页> 外文OA文献 >The short-term efficacy and safety of abiraterone acetate with prednisone in metastatic castration-resistant prostate cancer patients in vghtc

【2h】

The short-term efficacy and safety of abiraterone acetate with prednisone in metastatic castration-resistant prostate cancer patients in vghtc

机译：醋酸阿比特龙联合泼尼松对转移性去势抵抗性前列腺癌患者的短期疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hung Chi-Feng; Yang Cheng-Kuang; Ou Yen-Chuan; Ho Hao-Chung; Cheng Chen-Li; Chiu Kun-Yuan; Su Chung-Kuang; Wang Shian-Shiang; Chen Chuan-Shu; Li Jian-Ri; Chen Cheng-Che;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO) [J] . Javier Puente, Aranzazu González-del-Alba, Núria Sala-Gonzalez, BMC Cancer . 2019,第1期

机译：AbiraTerone醋酸盐加上泼尼松与Cabazitaxel的疗效和安全性作为后续治疗转移阉割前列腺癌中的后续治疗：结果来自前瞻性观察研究（Capro）
2. Antitumour Activity and Safety of Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Abiraterone Acetate Plus Prednisone for = 24 weeks in Europe [J] . de Bono Johann S., Chowdhury Simon, Feyerabend Susan, European urology . 2018,第1期

机译：先前用AbiraTerone醋酸盐加上抗泼尼松治疗的转移阉割前列腺癌患者依齐甲酰胺的抗肿瘤活性和安全性。欧洲24周
3. Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-na?ve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study [J] . Satoshi Fukasawa, Hiroyoshi Suzuki, Kazushiro Kawaguchi, Japanese journal of clinical oncology. . 2018,第11期

机译：AbiraTerone醋酸盐加上泼尼松在新诊断，转移激素-NA've患者中的疗效和安全性：纬度，随机，双盲，安慰剂控制，第3期研究的亚组分析
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO) [O] . Javier Puente, Aranzazu González-del-Alba, Núria Sala-Gonzalez, 2019

机译：一线多西紫杉醇在转移性去势抵抗性前列腺癌后的后续治疗中醋酸阿比特龙联合泼尼松与卡巴他赛的疗效和安全性：前瞻性观察研究（CAPRO）的结果
7. The short-term efficacy and safety of abiraterone acetate with prednisone in metastatic castration-resistant prostate cancer patients in vghtc [O] . Chi-Feng Hung, Cheng-Kuang Yang, Yen-Chuan Ou, 2015

机译：醋酸阿比特龙与泼尼松治疗转移性去势抵抗性前列腺癌患者的近期疗效和安全性

The short-term efficacy and safety of abiraterone acetate with prednisone in metastatic castration-resistant prostate cancer patients in vghtc

著录项

引文网络

相似文献

相关主题

期刊订阅